Loading
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 21 May 2026 for Entrada Therapeutics, Inc., €25k. Read the official filing
Filing timeline
BuySaleBernhardt G. Zeiher
Insider track record
Disclosed buys
2
Disclosed sells
0
Signal history
Closed purchases
Market purchases
2
Positive at T+90
100%
Median T+90
+24.3%
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +15.9%Entry US$6.56 · Close at T+90 US$7.60
- +265.9%Entry US$3.78 · Close at T+365 US$13.83
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Bernhardt G. Zeiher: trading record in brief
Bernhardt G. Zeiher has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Abeona Therapeutics Inc., Amylyx Pharmaceuticals, Inc. and Entrada Therapeutics, Inc. In total, 5 filings cover trades dated from 13 August 2024 to 20 May 2026.
Every open-market trade on record is a purchase: 2 purchases worth €59k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 3 share grants. So far in 2026, the count stands at 1 purchase and no sales.
The latest filing, published on 21 May 2026, reports an open-market purchase of €25k in Entrada Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Bernhardt G. Zeiher
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
5,000 shares@ US$5.86320.0092% mcap100.0% of flowCommon StockSEC:0001689375-26-000030:0
Canonical exit: 18 Aug 2026 (T+90)
37,313 shares0Common StockSEC:0001493152-26-003809:0
10,000 shares@ US$3.7005100.0% of flowCommon StockSEC:0000950170-25-043849:0
Canonical exit: 18 Jun 2025 (T+90)
36,101 shares0Common StockSEC:0001493152-25-004755:0
11,044 shares0Common StockSEC:0001493152-24-032393:0
5 of 5 declarations
